Related Experiment Video
Updated: May 3, 2026

12:04
Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
Published on: January 6, 2011
12.3K
Socio-Occupational Functioning after Subthalamic Deep Brain Stimulation in Parkinson's Disease.
Gabriele Imbalzano1,2, Elisa Montanaro3, Martina Giacchero4
1Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
Movement Disorders Clinical Practice
|May 2, 2026
Summary
Subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease (PD) patients shows satisfactory socio-occupational functioning. Individual factors like sex and GBA variants, not motor scores, influenced outcomes.
Area of Science:
- Neuroscience
- Neurosurgery
- Genetics
Background:
- Standard scales inadequately assess socio-occupational functioning in Parkinson's disease (PD) patients undergoing subthalamic nucleus deep brain stimulation (STN-DBS).
- Patient-reported outcomes are crucial for a holistic understanding of STN-DBS effectiveness.
Purpose of the Study:
- To characterize patient-reported socio-occupational functioning following STN-DBS.
- To identify clinical and demographic factors associated with socio-occupational functioning after STN-DBS.
Main Methods:
- A cohort of 34 PD patients was evaluated 9-18 months post-STN-DBS using a semi-structured interview.
- A composite socio-occupational functioning score (Q_mean) was calculated.
- Univariate screening and multivariate linear regression explored associations with clinical and demographic variables.
Main Results:
- The mean Q_mean score post-STN-DBS was 7.67 ± 0.86.
- Female sex was associated with higher socio-occupational functioning (P=0.039).
- Glucocerebrosidase (GBA) variants were associated with lower socio-occupational functioning (P=0.028).
Conclusions:
- Socio-occupational functioning is generally satisfactory after STN-DBS.
- Outcomes are influenced more by individual factors (sex, genetics) than traditional motor/neuropsychiatric measures.
- Incorporating socio-occupational assessments is recommended for comprehensive STN-DBS outcome evaluation.
Related Concept Videos
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28

